Skip to main content

Table 3 Results of reTURBT in various Tx indications

From: Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer

  

ReTURBT result

ReTURBT indication

n

Any residual disease

Residual Ta or T1 disease

Muscle-invasive tumor

Cis

Tx(x)–LG

3

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Tx(x)–HG

3

1 (33%)

0 (0%)

0 (0%)

1 (33%)

Tx(a)–LG

8

2 (25%)

2 (25%)

0 (0%)

0 (0%)

Tx(a)–HG

4

1 (25%)

0 (0%)

1 (25%)

0 (0%)

Tx(1)–LG

20

6 (30%)

1 (5%)

3 (15%)

2 (10%)

Tx(1)–HG

24

12 (50%)

6 (25%)

3 (13%)

3 (13%)

Total

62

22

9

7

6

  1. Tx(x) both detrusor muscle and subepithelial connective tissue lacking in the specimen; Tx(a) no intraepithelial invasion within available material, but detrusor muscle lacking in the specimen; Tx(1) intraepithelial invasion within available material and detrusor muscle lacking in the specimen; HG high-grade; LG low-grade